Literature DB >> 32319474

Lipidomic profiling of virus infection identifies mediators that resolve herpes simplex virus-induced corneal inflammatory lesions.

Cuiping Zhang1, Zuojian Hu, Ke Wang, Lujie Yang, Yue Li, Hartmut Schlüter, Pengyuan Yang, Jiaxu Hong, Hongxiu Yu.   

Abstract

Lipid mediators (LMs) play a pivotal role in the induction and resolution of inflammation. To identify and elucidate their involvement during virus infection, multiple reaction monitoring (MRM) based liquid chromatography-tandem mass spectrometry lipidomic profiling of 62 lipid species was performed in this study. Results show that RAW264.7 macrophages differentially produce specific LMs signals depending on difference in virus pathogenicity. Integration of large-scale lipidomics with targeted gene expression data revealed mediators, such as RVD3, 18-HEPE, 11(12)-EET etc. correlated with the pathogenic phase of the infection. The herpes simplex virus (HSV)-induced keratitis model demonstrates that 11(12)-EET treatment represents a novel alternative for treating viral infection.

Entities:  

Year:  2020        PMID: 32319474     DOI: 10.1039/d0an00263a

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  2 in total

Review 1.  Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections.

Authors:  Kumari Asha; Neelam Sharma-Walia
Journal:  Front Cell Infect Microbiol       Date:  2021-03-19       Impact factor: 5.293

2.  STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses.

Authors:  Isabelle K Vila; Hanane Chamma; Alizée Steer; Mathilde Saccas; Clara Taffoni; Evgenia Turtoi; Line S Reinert; Saqib Hussain; Johanna Marines; Lei Jin; Xavier Bonnefont; Mathieu Hubert; Olivier Schwartz; Soren R Paludan; Gaetan Van Simaeys; Gilles Doumont; Bijan Sobhian; Dimitrios Vlachakis; Andrei Turtoi; Nadine Laguette
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.